Adeno-associated virus-mediated osteoprotegerin gene transfer protects against joint destruction in a collagen-induced arthritis rat model - 25/10/12
Corresponding author. Tel.: +86 13020165957; fax: +86 2181873311.Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 6 |
| Iconographies | 5 |
| Vidéos | 0 |
| Autres | 0 |
Abstract |
Objective |
To evaluate the in vivo joint protection effect of recombinant adeno-associated virus-mediated gene transfer of human osteoprotegerin (rAAV-hOPG).
Methods |
Collagen-induced arthritis (CIA) rat model was established. CIA rats were randomly divided into three groups: CIA control group (PBS), rAAV-EGFP (enhanced green fluorescent protein) group and rAAV-hOPG (100μL/d) group, which received corresponding intra-articular injection treatment. The thickness of the palms and soles, arthritis index, radiological score, pathological score, bone damage factor and protein expression of inflammatory factors were measured and compared with normal control group rats.
Results |
Positive fluorescence of frozen section confirmed that rAAV-hOPG was efficiently transduced into the synovial tissues of test rats. In rAAV-hOPG group compared with CIA control group, the radiological score was 30.18% lower (P<0.05); the expression of OPG protein was 93.41% higher (P<0.05); the expression of matrix metalloproteinase-3 (MMP-3) protein was 35.38% lower (P<0.05); however, the expression of IL-1β was not significant; the scores of pannus and inflammation in rAAV-hOPG group have no significant difference.
Conclusion |
These results suggest that adeno-associated virus-mediated transfer of human osteoprotegerin is effectively transducted into the synovial tissues of CIA model, and protects against articular cartilage and bone destruction, but has no obvious efficiency on inflammation. The results also demonstrate that gene transfer using rAAV-hOPG may be a feasible and effective therapeutic candidate to treat or prevent joint destruction in inflammatory arthritis.
Le texte complet de cet article est disponible en PDF.Keywords : Osteoprotegerin, RAAV-hOPG, Gene therapy, Osteoclast, Collagen-induced arthritis
Plan
Vol 79 - N° 5
P. 482-487 - octobre 2012 Retour au numéro
Article précédent
- Clinical characteristics of anterior chest wall pain in spondyloarthritis: An analysis of 275 patients
- Muriel Elhai, Simon Paternotte, Vincent Burki, Anne Durnez, Isabelle Fabreguet, Eugénie Koumakis, Magali Meyer, Judith Payet, Fanny Roure, Maxime Dougados, Laure Gossec
- Genetic association analysis of GDF5 and ADAM12 for knee osteoarthritis
- Min-Ho Shin, Sung-Ji Lee, Seung-Jung Kee, Sang-Kook Song, Sun-Seog Kweon, Dong-Jin Park, Yong-Wook Park, Shin-Seok Lee, Tae-Jong Kim
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?